The UK is pledging 18 million dollars to disease and vaccine research in Senegal, after severe funding cuts by the U.S. The money will support the study of genetic material – to strengthen disease monitoring and vaccine production across West Africa.
Breakdown
- Scientists in Senegal are developing mRNA vaccines for diseases like Rift Valley Fever. 7s
- US funding cuts have impacted RNA vaccine research, prompting some scientists to relocate. 1m 6s
- The UK has pledged $18 million to support vaccine research and manufacturing in Senegal. 1m 39s
- Part of the funding will go towards mobile safety labs for rapid outbreak response. 1m 57s
- African researchers are increasingly serving as a global early warning system for pandemics. 2m 23s